DOXAPRAM HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for doxapram hydrochloride and what is the scope of patent protection?

Doxapram hydrochloride is the generic ingredient in two branded drugs marketed by Hikma, Chartwell Injectable, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for doxapram hydrochloride. Two suppliers are listed for this compound.

Summary for DOXAPRAM HYDROCHLORIDE

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	53
Clinical Trials:	14
Patent Applications:	291
What excipients (inactive ingredients) are in DOXAPRAM HYDROCHLORIDE?	DOXAPRAM HYDROCHLORIDE excipients list
DailyMed Link:	DOXAPRAM HYDROCHLORIDE at DailyMed

Recent Clinical Trials for DOXAPRAM HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Rehman Medical Institute - RMI	Phase 4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 3
Universitaire Ziekenhuizen Leuven	Phase 3

See all DOXAPRAM HYDROCHLORIDE clinical trials

Pharmacology for DOXAPRAM HYDROCHLORIDE

Drug Class	Respiratory Stimulant
Physiological Effect	Increased Medullary Respiratory Drive

Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE

Central Nervous System Stimulants
Respiratory System Agents

Anatomical Therapeutic Chemical (ATC) Classes for DOXAPRAM HYDROCHLORIDE

R07AB	Respiratory stimulants
R07A	OTHER RESPIRATORY SYSTEM PRODUCTS
R07	OTHER RESPIRATORY SYSTEM PRODUCTS
R	Respiratory system

US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Injectable	DOXAPRAM HYDROCHLORIDE	doxapram hydrochloride	INJECTABLE;INJECTION	076266-001	Jan 10, 2003	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	DOXAPRAM HYDROCHLORIDE	doxapram hydrochloride	INJECTABLE;INJECTION	073529-001	Jan 30, 1992		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	DOPRAM	doxapram hydrochloride	INJECTABLE;INJECTION	014879-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.